Profile
Dolby Family Ventures is a venture capital firm based in San Francisco, established in 2014. The firm is backed by the Dolby family and emphasizes funding for early-stage companies at the intersection of life sciences and technology. The team of seasoned investors is known for their unique insights, strategic focus, and support of innovative technologies, particularly in the biotech and pharmaceutical sectors.
Dolby Family Ventures invests primarily in precision neuroscience, life sciences platforms, climate, and digital technologies. They collaborate with entrepreneurs to bring groundbreaking research and development to market. While the site does not explicitly disclose typical check sizes, their investment involvement spans from Series A to Series D, indicating a significant investment capacity. They work closely with portfolio companies, leveraging strategic insights and a robust network to foster long-term partnerships and successful outcomes.
Notable investments include Motif Neurotech - wireless neuromodulation therapeutics for mental health, Montara Therapeutics - neurological drug platform, Therini Bio - vascular biology therapies, Ursa Major Technologies - propulsion systems for satellites, and Twelve - electrochemical processes for industrial waste. Their portfolio reflects a strong commitment to impactful technological advancements, particularly in neuroscience and therapeutics.
Industry
Dolby Family Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Dolby Family Ventures
|
Venture Capital (VC)
|
Aerospace
Biotechnology
SaaS
Security
Software
AI
Technology
Life Sciences
|
Seed
Series A
Series B
|
North America
Europe
Asia
|
$5-10 m
|
$196 M
|
December 2014
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.